Multidisciplinary teams: Involve pharmacists, educators, and care navigators to reduce burden and improve patient support
Boost is formulated with a clinically studied dose of Eriomin, a patented ingredient that has been shown in a human clinical trial to increase natural GLP-1 levels by 17% in 12 weeks supporting insulin production and blood sugar control
Compare Semaglutide with Tirzepatide, Retatrutide, and Cagrilintide by vial size, molecule class, category, catalog price, and access status
Hearing from others who have used the product can give you valuable insight into its potential benefits
Popularity of GLP-1s among younger generations amplifies sustainability concerns GLP-1 use increased dramatically among younger generations likely reflecting the recent approval of the drug for children 12 and older
At Town & Country Compounding, we regularly hear from patients concerned about sudden hair shedding a few months into therapy